Investing Profile
Ken Belotsky
VC
Founding Partner at Negev Capital. Leading VC in psychedelic drug development
negevcap.comTel Aviv, Israel
Your Intro Paths to Ken Belotsky
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Current Investing Position
Negev Capital Managing Partner
Investment Range
$500K - $3.0M
Sweet Spot
$1M
Investments On Record
6
Ken Belotsky is on these Sector & Stage Rankings
Ken Belotsky's Investments On Record (6)
Company | StageDateRound Size | Total Raised |
---|---|---|
Gilgamesh Pharmaceuticals | series BMay 2022$1 | $68M |
Mindstate Design Labs | Seed RoundFeb 2022$12M | $24M |
Delix Therapeutics | Series ASep 2021$70M | $70M |
Beckley Psytech | Series BAug 2021£58M | $80M £58M |
ATAI Life Sciences | Series BMar 2019$43M | $690M |
Small Pharma | Seed RoundApr 2017£830K | $1M £830K |
Investors who invest with Ken Belotsky
Founders who looked at Ken Belotsky's profile also looked at these Scouts & Angels